3qro
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor== | ==HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor== | ||
<StructureSection load='3qro' size='340' side='right' caption='[[3qro]], [[Resolution|resolution]] 1.62Å' scene=''> | <StructureSection load='3qro' size='340' side='right' caption='[[3qro]], [[Resolution|resolution]] 1.62Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3qro]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3qro]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hiv-1 Hiv-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QRO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3QRO FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DTD:DITHIANE+DIOL'>DTD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NK9:4-({(3S,4S)-4-[(3,5-DIHYDROXYBENZYL)AMINO]PYRROLIDIN-3-YL}[4-(TRIFLUOROMETHYL)BENZYL]SULFAMOYL)BENZAMIDE'>NK9</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=DTD:DITHIANE+DIOL'>DTD</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NK9:4-({(3S,4S)-4-[(3,5-DIHYDROXYBENZYL)AMINO]PYRROLIDIN-3-YL}[4-(TRIFLUOROMETHYL)BENZYL]SULFAMOYL)BENZAMIDE'>NK9</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3qrm|3qrm]], [[3qbf|3qbf]], [[3qpj|3qpj]], [[2qnn|2qnn]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3qrm|3qrm]], [[3qbf|3qbf]], [[3qpj|3qpj]], [[2qnn|2qnn]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3qro FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3qro OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3qro RCSB], [http://www.ebi.ac.uk/pdbsum/3qro PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3qro FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3qro OCA], [http://pdbe.org/3qro PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3qro RCSB], [http://www.ebi.ac.uk/pdbsum/3qro PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3qro ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 16: | Line 17: | ||
</StructureSection> | </StructureSection> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
| - | [[Category: | + | [[Category: Hiv-1]] |
[[Category: Heine, A]] | [[Category: Heine, A]] | ||
[[Category: Klebe, G]] | [[Category: Klebe, G]] | ||
Revision as of 11:57, 4 August 2016
HIV-1 protease (mutant Q7K L33I L63I) in complex with a three-armed pyrrolidine-based inhibitor
| |||||||||||
